Palbociclib N-β-D-Glucuronide is a derivative of Palbociclib (P139900) which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
Molecular Formula:C30H36N7NaO8
Solubility:DMSO (Slightly(, Methanol (Slightly), Water (Slightly)
Molecular Weight:645.64
Storage and Stability:Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.